Purified Water, Propanediol, Butyloctyl Salicylate, Dibutyl Adipate, Ethylhexyltriazone, Terephthalylidene Dicamphorsulfonic Acid, Niacinamide, Tromethamine, Polyglyceryl-3distearate, Octyldodecanol , Cetearyl Alcohol, 1,2-hexanediol, Pentylene Glycol, Diethylaminohydroxybenzoylhexylbenzoate, Caprylylmethicone, Polysilicone-15, Chickweed Extract, Sunflower Extract, Cowberry Extract, Tara Fruit Extract, Kotoni Extract, Lakemosa Rhizome Root Extract, Bogum Cactus Fruit Extract, White Patterned Thistle Extract, Evening Primrose Oil, Sodium Hyaluronate (1.6 ppb), Hydrogenated Lecithin, Polymethylsilsesquioxane, Butylene Glycol Lycol, Glyceryl Stearate, Bis-ethylhexyloxyphenol Methoxyphenyltriazine, Potassium Cetyl Phosphate, Methyl Propanediol, Poly C10-30 Alkyl Acrylate, Carbomer, Glyceryl Stearate Citrate, Acrylate/ C10-30 Alkyl Acrylate Crosspolymer, Ethylhexyl Glycerin, Ammonium Acryloyl Dimethyl Taurate/vpicopolymer, Adenosine, Polyether-1, Biosaccharide Gum-1, Panthenol, Tocopherol, Glycerin, Glutathione (100 ppb), Ectoin, Glyceryl Polymethacrylate, Glyceryl Glucoside, Maltodextrin, Hydrolyzed Vegetable Protein, Propylene Glycol, Sodium Hyaluronate Crosspolymer (5.08 ppb), Dimethylsilanol Hyaluronic Acid Ronate (0.15 ppb), Resveratrol, Retinyl Palmitate, Biotin, Benzyl Glycol, Cyanocobalamin, Ceramide Np, Sodium Acetylated Hyaluronate (0.04 ppb), Sodium Ascorbyl Phosphate, Sodium Hyaluronate Ronate Dimethylsilanol (0.05 ppb), Acetyl Hexapeptide-8, Copper Tripeptide-1, Caprylyl Glycol, Tocopheryl Acetate, Tripeptide-1, Thiamine HCL, Palmitoyl Tetrapeptide-7, Palmyra Toyl Tripeptide-1, Palmitoyl Pentapeptide-4, Potassium Hyaluronate (0.1 ppb), Polyglyceryl-10 Stearate, Polyacid, Pyridoxine, Phytosphingosine, Hydroxypropyltrimonium Hyaluronate (0.08 ppb), Hydrolyzed Glycosaminoglycan, Hydrolyzed Sodium Hyaluronate (0.15 ppb), Hydrolyzed Hyaluronic Acid (0.4 ppb), Hyaluronic Acid (0.105 ppb), Hexapeptide-9, Fragrance
GI dysfunctions are a key non-motor symptom of PD, often appearing at a very early stage of the disease
A 24 h time point was chosen based on a previous report of using this time period for transfecting or treating 3T3-L1 cells with NNMT anti-sense oligonucleotides or a small molecule NNMT product inhibitor (1-MNA), respectively, for phenotypic measures
How does CJC 1295/Ipamorelin work
